Currently being updated.
Automatic reload in seconds.


 
Subscribe: RSS Podcasts iTunes
wikiofthedaymasto.ai
  Buy WotD Stuff!!
Episode 896             Episode 898
Episode 897

Specialty drugs in the United States
Thu, 2019-Oct-17 01:48 UTC
Length - 3:07

Direct Link

Welcome to popular Wiki of the Day where we read the summary of a popular Wikipedia page every day.

With 506,651 views on Wednesday, 16 October 2019 our article of the day is Specialty drugs in the United States.

Specialty drugs or specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch. Specialty drugs are often biologics—"drugs derived from living cells" that are injectable or infused (although some are oral medications). They are used to treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H. I. V. psoriasis, inflammatory bowel disease and hepatitis C. In 1990 there were 10 specialty drugs on the market, in the mid-1990s there were fewer than 30, by 2008 there were 200, and by 2015 there were 300. Drugs are often defined as specialty because their price is much higher than that of non-specialty drugs. Medicare defines any drug for which the negotiated price is $670 per month or more, as a specialty drug which is placed in a specialty tier that requires a higher patient cost sharing. Drugs are also identified as specialty when there is a special handling requirement or the drug is only available via a limited distributions network. By 2015 "specialty medications accounted for one-third of all spending on drugs in the United States, up from 19 percent in 2004 and heading toward 50 percent in the next 10 years", according to IMS Health, which tracks prescriptions. According to a 2010 article in Forbes, specialty drugs for rare diseases became more expensive "than anyone imagined" and their success came "at a time when the traditional drug business of selling medicines to the masses" was "in decline". In 2015 analysis by The Wall Street Journal suggested the large premium was due to the perceived value of rare disease treatments which usually are very expensive when compared to treatments for more common diseases.

This recording reflects the Wikipedia text as of 01:48 UTC on Thursday, 17 October 2019.

For the full current version of the article, see Specialty drugs in the United States on Wikipedia.

This podcast is produced by Abulsme Productions based on Wikipedia content and is released under a Creative Commons Attribution-ShareAlike License.

Visit wikioftheday.com for our archives, sister podcasts, and swag. Please subscribe to never miss an episode. You can also follow @WotDpod on Twitter.

Abulsme Productions produces the current events podcast Curmudgeon's Corner as well. Check it out in your podcast player of choice.

This has been Kimberly. Thank you for listening to popular Wiki of the Day.

Archive
2017:MayJunJulAugSepOctNovDec
2018:JanFebMarAprMayJunJulAugSepOctNovDec
2019:JanFebMarAprMayJunJulAugSepOctNovDec
2020:JanFebMarAprMayJunJulAugSepOctNovDec
2021:JanFebMarAprMayJunJulAugSepOctNovDec
2022:JanFebMarAprMayJunJulAugSepOctNovDec
2023:JanFebMarAprMayJunJulAugSepOctNovDec
2024:JanFebMarAprMayJunJulAugSepOctNov

Most Recent Episodes


Feedback welcome at feedback@wikioftheday.com.

These podcasts are produced by Abulsme Productions based on Wikipedia content.

They are released under a Creative Commons Attribution-ShareAlike 3.0 Unported License.

Creative Commons License

Abulsme Productions also produces Curmudgeon's Corner, a current events podcast.

If you like that sort of thing, check it out too!


Page cached at 2024-11-18 19:13:55 UTC
Original calculation time was 0.1602 seconds

Page displayed at 2024-11-21 08:57:48 UTC
Page generated in 0.0022 seconds